Director of Intellectual Property jobs in United States
cer-icon
Apply on Employer Site
company-logo

Innovent Biologics · 3 weeks ago

Director of Intellectual Property

Innovent Biologics is a company focused on advancing research and innovation in the biotechnology sector. The Director of Intellectual Property will lead IP support for research projects, manage patent strategies, and negotiate licensing agreements while collaborating with various internal teams to protect innovations.

BiopharmaBiotechnologyManufacturing

Responsibilities

Lead and oversee patent prosecution activities, including drafting, filing, and managing patent applications
Collaborate with R&D teams to identify patentable inventions and ensure robust protection
Deliver freedom-to-operate (FTO), patent validity, and infringement analysis to inform decision-making across research, development and commercial projects
Develop, implement, and oversee global IP strategy for Fortvita and Innovent research projects, ensuring alignment with business objectives
Monitor and manage the lifecycle of patents to optimize portfolio value
Negotiate, draft, and review licensing agreements, collaboration agreements, and other related commercial contracts
Work with internal stakeholders to ensure agreements align with Innovent IP and business strategies
Advise on IP ownership, rights, and obligations arising from agreements
Closely collaborate with other IP team members to develop process and guidance to manage IP risks
Conduct IP due diligence for in-license and out-license deals
Develop and enforce IP-related policies, processes, and compliance programs
Lead and manage IP disputes, including infringement litigation, oppositions, and other proceedings
Collaborate with external counsel to achieve favorable outcomes in disputes
Support pre-litigation risk assessments
Partner with R&D, legal, commercial, and regulatory teams to align IP protection with product development and market strategies
Support business development efforts, including drafting and negotiating IP-related terms in licensing and partnership agreements

Qualification

J.D.USPTO registrationPatent lawIntellectual property lawLife sciences degreeGlobal patent portfolio managementLicensing agreementsEntrepreneurial mindsetChinese (Mandarin)CommunicationStrategic thinkerCollaborative mindsetWritten communication

Required

J.D. and licensed to practice law in at least one U.S. jurisdiction (active and in good standing)
USPTO registration and eligibility to practice patent law
Advanced scientific degree (M.S. or Ph.D.) in life sciences, such as biology, chemistry, biochemistry, or a related field
At least 5 years of intellectual property law experience combined experience in top-tier law firms and in-house legal roles, with a focus on life sciences or biotechnology sectors
Proven track record in advising IP risks in deals, for example at least independently supported 2-3 deals (including in-license, out-license or collaboration)
Strong global perspective, with experience of managing patent portfolios across the U.S., EU, China and Japan
Experience of managing trademark support is a plus
Excellent organizational communication and coordination skills
Strategic and pragmatic thinker with hands-on execution ability in fast paced organization
Collaborative, agile and comfortable working cross-functionally in a diver culture
Entrepreneurial and creative mindset with flexibility to pivot quickly as business needs evolve
In depth knowledge of global drug research and development
Excellent written and oral communication skills — able to translate complex IP concepts for diverse stakeholders

Preferred

Proficiency or working knowledge of Chinese (Mandarin) is preferred

Company

Innovent Biologics

twittertwittertwitter
company-logo
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.

Funding

Current Stage
Public Company
Total Funding
$1.52B
Key Investors
TakedaSanofiCapital Group Private Markets
2025-10-21Post Ipo Equity· $100M
2025-06-26Post Ipo Equity· $547.83M
2022-08-04Post Ipo Equity· $308.29M

Leadership Team

leader-logo
Qinwei Zhou
COO
linkedin
leader-logo
Ronald Ede
Executive Director of the Board
linkedin
Company data provided by crunchbase